Effects of Supplementation of Compound Nutrients on Plasma Homocysteine in

See also
Status	Clinical Trial	Phase
Completed	`NCT00172250` - The Study of Relationship of Plasma Concentrations of Folic Acid, Vitamin B and Homocysteine With Carotid Atherosclerosis and Endothelium-Dependent Vasodilatation of Geriatric and Young Patients in the Ambulatory Care Department of NTUH	N/A
Completed	`NCT02575092` - The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment	Phase 2/Phase 3
Enrolling by invitation	`NCT03595163` - Effects of Propofol and Sevoflurane on Blood Folic Acid and Homocysteine Concentrations in Children	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT00172250 - The Study of Relationship of Plasma Concentrations of Folic Acid, Vitamin B and Homocysteine With Carotid Atherosclerosis and Endothelium-Dependent Vasodilatation of Geriatric and Young Patients in the Ambulatory Care Department of NTUH

N/A

Completed

NCT02575092 - The Relationship Between HHcy and Contrast-induced Nephropathy in Hypertensive Patients After Coronary Artery Diagnosis and Treatment

Phase 2/Phase 3

Enrolling by invitation

NCT03595163 - Effects of Propofol and Sevoflurane on Blood Folic Acid and Homocysteine Concentrations in Children

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT06363565
Study type	Interventional
Source	Sun Yat-sen University
Contact	Huilian Zhu, professor
Phone	+86 20 87331811
Email	zhuhl@mail.sysu.edu.cn
Status	Recruiting
Phase	N/A
Start date	June 1, 2023
Completion date	December 31, 2025

Effects of Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese Adults

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms